Numerous experimental applications of allopurinol (4-hydroxy [3,4-d] pyrazolo pyrimidine), a xanthine oxidase inhibitor (1), have been attempted (2-6) mostly with success for the treatment of symptoms accompanying hypoxia and tissue purine loss such as in cases of myocardial ischemia and kidney transplantation.
These studies suggest that xanthine oxidase inhibitors have the potential for more wide application in the therapy of other diseases as well as for gout and hyperuricemia. However, for the development of a new inhibitor, no convenient in vivo testing system for the inhibitory action of substances on xanthine oxidase is yet available in spite of the fact that the activity is easily tested in vitro. Therefore, we attempted a trial experiment to prevent the development of "adenine kidney" with inhibitors as an experimental model since adenine kidney is caused by the adminis tration of a large amount of adenine to rats which causes (7) a significant deposit of 2,8 dihydroxyadenine, an oxidized product of adenine produced by xanthine oxidase.
Milk xanthine oxidase purchased from Boehringer Mannheim GmbH, was incubated with xanthine as a substrate as described previously (8) in the presence of various concentrations of allopurinol or 5-formyl uracil, The latter has been also reported (9) to be a xanthine oxidase inhibitor and was obtained from a microbial source (8) .
To test the in vivo inhibition, the inhibitors were suspended in 0.5% carboxymethyl cellulose and orally administered to male Wistar rats weighing about 200 g for two times; 1 hr before and 4 hr after adminis tration of adenine dissolved in 0.4N-lactic acid. Adenine was administered either orally (450 mg/kg) or intraperitoneally (225 mg/ kg). Control animals received the cor responding vehicles. Rats were decapitated 7 hr after administration of adenine or the vehicle. Their kidneys were dissected out, washed with ice-cold saline, blotted, weighed, and homogenized in 5 volumes of 10% perchloric acid which was previously chilled to avoid the liberation of free purines from nucleic acids. Acid insoluble residue was washed with the acid twice on centri fugation. The acidic extracts were combined, appropriately diluted with the acid, and their extinctions were determined at various wavelengths ranging from 240-320 nm on a Hitachi digital spectrophotometer, Model 102. For convenience, the data in this paper are given as optical density units at a given wavelength/g kidney which was calculated as follows: The extinctions were corrected for dilution and multiplied by the total volume of the original acidic extracts to give total optical density units, which were then divided by kidney weights (i.e., optical density unit/g=extinction read x dilution factorxvolume of extract/kidney weight).
At dissection, kidneys of rats given adenine only, adenine plus allopurinol (5 and 10 mg/kg), or adenine plus 5-formyl uracil (20 mg/kg) were more or less enlarged, pale and yellow-stippled; these were signs characteristic of adenine kidney as described previously (7) . In contrast, kidneys were apparently normal in rats given vehicles, adenine plus allopurinol (more than 20 mg/ kg), or allopurinol alone.
Neutralization with sodium hydroxide of the kidney extracts of rats given adenine alone resulted in precipitation of a white powder posessing a i.max at 305 nm and a Jm;n at 260 nm (Fig. 1a) , whereas no precipitates were yielded from neutralized extracts of the control rat kidneys.
Thus the powder was found to be 2,8-dihydroxy adenine (7) and its deposit was evident in these adenine-treated animals.
Figure 1 also shows the typical UV absorption spectra of the tissue extracts of each rat. A distinct difference in the spectra is obvious at wavelengths of around 260 nm and around 305 nm. At 260 nm which is a 2mat of adenine, the difference between animals was rather too complex for a definite conclusion;
however, high extinctions of rats given adenine plus allopurinol (20 mg/ kg in Fig. 1 a and 30 mg/kg in Fig. 1b) suggest that either unchanged adenine or adenine nucleotides was accumulated in their kidneys.
The latter case is likely since allopurinol enhances purine salvage (10).
In contrast, the difference at 305 nm, the 2rnax of 2,8-dihydroxyadenine (7), is clear between the animals.
In control rats, the extinction at 305 nm was practically negligible while that in the adenine-treated rats was apparently high. The peak height of extinctions seems to become lower dependently on allopurinol dose (Fig. 1b) . Therefore, it is concluded that the prevention of 2,8-dihydroxyadenine deposition in the kidney can he specifically monitored by reading extinctions of the kidney extracts at this wavelength. These results suggest that 5 formyluracil exerts only restricted inhibitory activity in vivo while its activity in vitro is as potent as that of allopurinol.
When adenine was given intraperitoneally to rats at 1 /2 the dose of oral administration (experiment Ill), deposition of 2,8-dihydroxy adenine was also evident and the kidneys of rats treated with 20 mg/kg of allopurinol orally were apparently normal ( Fig. 1 a and Table 1 ). Therefore, the prevention of 2,8 dihydroxyadenine deposit in the kidney from oral adenine observed above by oral allopurinol is not due to the disturbance of adenine absorption in the digestive tracts by the drug, but due to the inhibition of xanthine oxidase in vivo.
In conclusion, prevention of adenine kidney after administration of a substance can be a measure for its actual inhibitory activity of xanthine oxidase in vivo. The assay procedure is quite simple and rapid and can be done by comparing the extinctions at 305 nm of the acidic extract of rat kidneys after administration of adenine and adenine plus the test substance.
